Marshall Wace’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184K | Buy |
+79,498
| New | +$184K | ﹤0.01% | 2327 |
|
|
2025
Q1 | – | Sell |
-138,111
| Closed | -$239K | – | 2920 |
|
|
2024
Q4 | $239K | Sell |
138,111
-347,915
| -72% | -$602K | ﹤0.01% | 2148 |
|
|
2024
Q3 | $977K | Sell |
486,026
-300,068
| -38% | -$603K | ﹤0.01% | 1531 |
|
|
2024
Q2 | $1.76M | Sell |
786,094
-244,563
| -24% | -$548K | ﹤0.01% | 1305 |
|
|
2024
Q1 | $2.96M | Buy |
+1,030,657
| New | +$2.96M | ﹤0.01% | 1058 |
|
|
2023
Q1 | – | Sell |
-69,296
| Closed | -$157K | – | 2599 |
|
|
2022
Q4 | $157K | Buy |
+69,296
| New | +$157K | ﹤0.01% | 2138 |
|
|
2022
Q3 | – | Sell |
-91,670
| Closed | -$341K | – | 3084 |
|
|
2022
Q2 | $341K | Sell |
91,670
-47,716
| -34% | -$177K | ﹤0.01% | 2292 |
|
|
2022
Q1 | $909K | Buy |
139,386
+81,028
| +139% | +$528K | ﹤0.01% | 1887 |
|
|
2021
Q4 | $679K | Buy |
+58,358
| New | +$679K | ﹤0.01% | 2044 |
|